No doubt most breast specialists have seen this recent report from the outstanding genetics program at Stanford, led by Dr. Allison Kurian. This study documents
Question: Following a lumpectomy for breast cancer, I placed a 3-D partial breast prosthetic+marker device (BioZorb) for partial breast construction as part of the oncoplastic
Multicenter, community based, clinical research studies completed.
Over 20 physicians and >500 patients
Sixteen poster and oral presentations
TME - Industry collaboration with independent data review, analysis and